Inventor
RICHTER ANNE
DE10 patents
⚠️ This page may combine multiple inventors who share the name “RICHTER ANNE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MILTENYI BIOTEC BV & CO KG
7 patentsUS11419935B2Aug 23, 2022
Immunotherapy method comprising administering a combination of immune effector cells and non-target hematopoietic cells
MILTENYI BIOTEC BV & CO KG5 citations82
US12246065B2Mar 11, 2025
Immunotherapy of cancer patients using CAR T or CAR NK cells combined with hematopoietic cells that have a modified or deleted target antigen
MILTENYI BIOTEC BV & CO KG1 citations73
US11883494B2Jan 30, 2024
Combination of immune effector cells specific for a target antigen and hematopoietic calls that express the target antigen in an altered form
MILTENYI BIOTEC BV & CO KG2 citations71
US12576148B2Mar 17, 2026
Engineered immune effector cells for cancer immunotherapy that are resistant to fratricide by virtue of having genetically modified surface antigens
MILTENYI BIOTEC BV & CO KG0 citations61
US12521434B2Jan 13, 2026
Hematopoietic cells with a modified CD antigen for reducing side effects of cancer immunotherapy
MILTENYI BIOTEC BV & CO KG0 citations61
US12318446B2Jun 3, 2025
Reducing side effects of immunotherapy using genetically modified hematopoietic cells
MILTENYI BIOTEC BV & CO KG0 citations61
US12181475B2Dec 31, 2024
Reagents for detection of chimeric antigen receptor cells
MILTENYI BIOTEC BV & CO KG0 citations50
MILTENYI BIOTEC GMBH
3 patentsUS11033619B2Jun 15, 2021
Combination of immune effector cells specific for a target antigen and hematopoietic cells that express the target antigen in an altered form
MILTENYI BIOTEC GMBH15 citations93
US10201606B2Feb 12, 2019
Combination immunotherapy of antigen-recognizing receptors and hematopoietic cells for the treatment of diseases
MILTENYI BIOTEC GMBH18 citations93
US10871490B2Dec 22, 2020
Assay for detection of chimeric antigen receptor T cells
MILTENYI BIOTEC GMBH1 citations57